Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shijiazhuang Aopharm is a Chinese pharmaceutical company specializing in the export and supply of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and fine chemicals. Based in Shijiazhuang, the company serves as a bridge between Chinese manufacturers and the global healthcare market, providing a wide range of products including analgesics, antibiotics, and vitamins. Their business model focuses on quality control, sourcing, and international distribution rather than internal drug discovery or clinical development. Aopharm's portfolio includes high-demand substances such as paracetamol and metformin, catering to pharmaceutical manufacturers worldwide. The company maintains a strong presence in the international trade of chemical raw materials, ensuring compliance with various global regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shijiazhuang Aopharm.